QuintilesIMS to Participate in William Blair Growth Stock Conference on June 14, 2017
June 05 2017 - 4:15PM
Business Wire
Quintiles IMS Holdings, Inc. (NYSE:Q), a leading global provider
of information, technology services and contract research to the
healthcare and life sciences industries, announced today that Mike
McDonnell, executive vice president and chief financial officer,
will speak at the William Blair 37th Annual Growth Stock Conference
in Chicago on Wednesday, June 14, 2017 at 1:20 p.m. CDT / 2:20 p.m.
EDT.
A live audio webcast of the presentation will be available on
the QuintilesIMS Investor Relations website at
http://ir.quintilesims.com. A replay of the webcast also will be
available later that day.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated
to helping its clients improve their clinical, scientific and
commercial results. Formed through the merger of Quintiles
Transnational and IMS Health, QuintilesIMS’s approximately 50,000
employees conduct operations in more than 100 countries. Companies
seeking to improve real-world patient outcomes through treatment
innovations, care provision and access can leverage QuintilesIMS’s
broad range of healthcare information, technology and service
solutions to drive new insights and approaches. QuintilesIMS
provides solutions that span clinical to commercial, bringing
customers a unique opportunity to realize the full potential of
innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS
protects individual privacy while managing information to drive
healthcare forward. These insights and execution capabilities help
biotech, medical device and pharmaceutical companies, medical
researchers, government agencies, payers and other healthcare
stakeholders in the development and approval of new therapies, and
to identify unmet treatment needs and understand the safety,
effectiveness and value of pharmaceutical products in improving
overall health outcomes. To learn more, visit
www.QuintilesIMS.com.
Click here to subscribe to Mobile Alerts for QuintilesIMS.
QUINTILESIMSFIN
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170605005759/en/
QuintilesIMS Investor RelationsAndrew Markwick,
+1-973-257-7144andrew.markwick@quintilesims.comorQuintilesIMS Media
RelationsTor Constantino,
+1-484-567-6732tor.constantino@quintilesims.com
IQVIA (NYSE:IQV)
Historical Stock Chart
From Mar 2024 to Apr 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2023 to Apr 2024